Acupuncture point stimulation device for treating Alzheimer disease and use method thereof

By designing a self-operated acupoint stimulation device, using high and low electric frequency pulse signals to simulate electric acupuncture treatment, the problem of high time and money cost of long-term acupuncture treatment in patients with Alzheimer's disease is solved, and personalized treatment is achieved and simplified The operation process has been reduced and the burden on the family members.

CN118975931APending Publication Date: 2024-11-19GUANGANMEN HOSPITAL CHINA ACAD OF CHINESE MEDICAL SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411108689.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

Patients with Alzheimer's disease need long-term and continuous acupuncture treatment, but due to its complexity and the decline in patient cognitive ability, existing acupuncture treatment requires professional operation and family accompanying, resulting in high time and money costs and difficulty in persisting for a long time.

Method used

A acupuncture point stimulation device is designed, including the front wear part, the back wear part and the upper wear part. Through the electric needle and the stimulation control part, high and low electric frequency pulse signals are generated, and the patient's tolerance level and acupoint position are stimulated to simulate electric Acupuncture treatment simplifies operations and reduces the need for expertise.

Benefits of technology

This device can accurately stimulate the acupuncture points in the head and brain, improve the symptoms of Alzheimer's disease, delay the progress of the disease, and reduce the cost of treatment. Patients can operate it themselves to reduce the burden on their families, and the treatment effect is personalized.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118975931A_ABST
    Figure CN118975931A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of cognitive rehabilitation equipment, and relates to an acupoint stimulation device for treating Alzheimer's disease and a use method thereof.The acupoint stimulation device comprises a front wearing part, a rear wearing part and an upper wearing part which are connected through connecting parts, the front wearing part, the rear wearing part and the upper wearing part are each provided with at least one stimulation part, and the stimulation parts are electrically connected with a stimulation control part; the stimulation control part is electrically connected with the stimulation generation part; the stimulation generation part is used for generating pulse signal waves with high electric frequency and low electric frequency; the stimulation control part is used for generating a combination of high-electric-frequency pulse signal waves and low-electric-frequency pulse signal waves and a combination of stimulation parts needing to be started according to the type of the Alzheimer's disease and the tolerance degree of the patient; the stimulation parts are used for stimulating the corresponding acupuncture points according to the combination of the pulse signal waves of the high electric frequency and the low electric frequency and the combination of the stimulation parts needing to be started. The device can accurately position the acupuncture points in the brain region of the head and stimulate the acupuncture points, so that the Alzheimer's disease is effectively improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to an acupoint stimulation device for treating Alzheimer's disease and a use method thereof, belonging to the technical field of cognitive rehabilitation equipment. Background Art

[0002] Alzheimer's disease (AD) is a common chronic degenerative disease among neurological diseases. Its main clinical manifestations are progressive memory loss, loss of executive and recognition abilities, which can have a significant impact on the daily lives of the elderly and are accompanied by varying degrees of mental and behavioral disorders. With the acceleration of the aging process of society, the number of people suffering from Alzheimer's disease has increased year by year, bringing huge challenges to medical and health care.

[0003] Alzheimer's disease is an irreversible degenerative disease of the central nervous system. The clinical pathogenesis is still unclear. The main pathological hypotheses include abnormal deposition of amyloid-β protein to form senile plaques and excessive phosphorylation of Tau protein to form neurofibrillary deposition. Currently, drug treatment is mainly symptomatic treatment with limited therapeutic effect.

[0004] In recent years, the treatment of Alzheimer's disease through traditional Chinese medicine has received extensive attention and research. Acupuncture, as a non-drug treatment method, can improve patients' symptoms to a certain extent, delay the progression of the disease, and has the advantages of being non-toxic, having no side effects, and being able to be used for a long time. However, the effect of acupuncture treatment requires long-term and continuous stimulation to be apparent, and acupuncture treatment requires professional physicians to operate, and patients need to come to the hospital regularly to complete the treatment. Most patients with Alzheimer's disease are elderly people with cognitive decline, with obvious memory decline, poor orientation to time and place, and poor language and comprehension abilities. It is risky to come to the hospital alone for acupuncture treatment, so family members need to accompany them every time they see a doctor, which requires a lot of time, energy and money in the process. Alzheimer's disease is a chronic disease that requires long-term treatment, so patients and their families need to spend a long time and money for treatment, which puts a great burden on patients and their families. Summary of the invention

[0005] The technical problem to be solved by the present invention is how to provide an acupoint stimulation device for treating Alzheimer's disease and a method of using the device, which can accurately locate the acupoints in the brain area of ​​the head and stimulate the acupoints, thereby effectively improving Alzheimer's disease. The device is easy to operate and does not require professional knowledge. Patients can operate it themselves at home, saving time and money costs for patients and their families.

[0006] In order to solve the above technical problems, the present invention provides an acupoint stimulation device for treating Alzheimer's disease, comprising: a front wearing part, a rear wearing part, an upper wearing part, a connecting part, a stimulation generating part, a stimulation control part and a stimulation part; the front wearing part, the rear wearing part and the upper wearing part are connected by the connecting part, and at least one stimulation part is arranged on each of the front wearing part, the rear wearing part and the upper wearing part, and the stimulation part is electrically connected to the stimulation control part, and the stimulation control part is electrically connected to the stimulation generating part; the stimulation generating part is used to generate high-frequency and low-frequency pulse signal waves; the stimulation control part is used to generate a combination of high-frequency and low-frequency pulse signal waves, and a combination of stimulation parts that need to be activated according to the type of Alzheimer's disease and the tolerance of the patient; the stimulation part is used to stimulate the corresponding acupoints according to the combination of high-frequency and low-frequency pulse signal waves, and the combination of stimulation parts that need to be activated.

[0007] Furthermore, the stimulation part includes a chassis and independently powered electric needle heads arranged in a matrix on the chassis. The electric needle heads are used to measure the resistance of the skin, determine the specific location of the acupoints based on the resistance measurement results, simulate the depth of electric needle stimulation by regulating the waveform and amplitude of the stimulation voltage / current of the electric needle heads, and use variable frequency electric pulses to regulate the stimulation phase and simulate the angle of electric needle stimulation.

[0008] Furthermore, there are two stimulation parts arranged in the middle inner side of the front wearing part, namely the upper front stimulation part and the lower front stimulation part; the stimulation parts arranged on both sides of the front wearing part are the left stimulation part and the right stimulation part; there are two stimulation parts arranged in the middle inner side of the rear wearing part, namely the rear left stimulation part and the rear right stimulation part, which are symmetrically arranged along the midline of the rear wearing part; the stimulation part arranged on the lower side of the upper wearing part includes an upper main stimulation part and an upper secondary stimulation part, and the upper secondary stimulation part is distributed in a straight line in four directions of up, down, left and right with the upper main stimulation part as the center; the upper main stimulation part and each of the upper stimulation parts are provided with an electric needle head with independent power supply.

[0009] Furthermore, the front upper stimulation part corresponds to the acupuncture point Shenting, the front lower stimulation part corresponds to the acupuncture point Yintang, the left stimulation part and the right stimulation part correspond to the acupuncture points Taiyang on both sides, the rear left stimulation part and the rear right stimulation part correspond to the acupuncture points Fengchi on both sides, the upper main stimulation part corresponds to the acupuncture point Baihui, and the upper secondary stimulation part corresponds to the acupuncture point Si Shencong.

[0010] Furthermore, the front upper stimulation portion and the front lower stimulation portion are detachably arranged on the front wearing portion, the rear left stimulation portion and the rear right stimulation portion are detachably arranged on the rear wearing portion, and the upper main stimulation portion and the upper secondary stimulation portion are detachably arranged on the upper wearing portion.

[0011] Furthermore, the front wearing part, the rear wearing part and the upper wearing part can all be finely adjusted relative to the connecting part, and the positions of the front wearing part, the rear wearing part and the upper wearing part can be finely adjusted according to the resistance measurement results obtained by the electric needle head so that the electric needle head is aligned with the acupuncture point.

[0012] Furthermore, the connecting part is a fabric with high elongation and high resilience made of stretch yarn, an elastic band or a slide rail. However, when the connecting part is a slide rail, the front wearing part, the rear wearing part and the upper wearing part are all sliders arranged on the slide rail.

[0013] Furthermore, the combination of the high-frequency and low-frequency pulse signal waves is that the low-frequency pulse signal is 2Hz and the high-frequency pulse signal is 100Hz. After the high-frequency pulse signal is output for a preset time, the low-frequency pulse signal is output, alternating between high and low frequencies.

[0014] Furthermore, the stimulation control unit includes a display screen and an alarm unit, the display screen is used to display the combination of the high-frequency and low-frequency pulse signal waves, and parameter input is performed through the display screen, and the alarm unit performs sound wave or video alarm when the device is in an open circuit or short circuit state or exceeds the maximum set current.

[0015] The present invention also discloses a method for using an acupuncture point stimulation device for treating Alzheimer's disease. The acupuncture point stimulation device for treating Alzheimer's disease described in any of the above items comprises the following steps: wearing the front wearing part, the rear wearing part and the upper wearing part on the forehead, the back of the head and the top of the head of the user respectively; detecting the skin resistance to determine the accurate position of the acupuncture point, and fine-tuning the position of the front wearing part, the rear wearing part and the upper wearing part; starting the stimulation generating part and the stimulation controlling part to generate a combination of high-frequency and low-frequency pulse signal waves and a combination of stimulation parts to be started according to the tolerance level of the Alzheimer's patient, and energizing the electric needle heads on the front wearing part, the rear wearing part and the upper wearing part in sequence; if the energization reaches a preset time or the patient feels unwell, stopping the energization and ending the acupuncture point stimulation.

[0016] The present invention adopts the above technical solution, which has the following advantages:

[0017] 1. The present invention formulates a targeted treatment plan according to the severity of the patient's illness, that is, a combination of high-frequency and low-frequency pulse signal waves, and a combination of stimulation parts that need to be activated, wherein the insertion depth and angle of the electric needle head in the stimulation part can be adjusted. The depth and angle of the electric needle head are adjusted according to different treatment plans and the patient's tolerance to pain, making the treatment plan more personalized and targeted, making it easier for patients to adhere to it.

[0018] 2. The present invention adopts 2 / 100Hz variable frequency pulses to accurately stimulate the electrodes on the acupuncture points. It is a therapeutic wearable device that simulates electroacupuncture stimulation, which can improve the symptoms of Alzheimer's disease and delay the progression of the disease.

[0019] 3. The present invention can automatically find the accurate acupuncture point location, solving the problem of poor treatment effect caused by inaccurate acupuncture points. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 A schematic diagram of the three-dimensional structure of an acupoint stimulation device for treating Alzheimer's disease according to the present invention;

[0021] Figure 2 It is a front view structural schematic diagram of an acupoint stimulation device for treating Alzheimer's disease according to the present invention;

[0022] Figure 3 A schematic diagram of the distribution position of the stimulation part of an acupoint stimulation device for treating Alzheimer's disease according to the present invention;

[0023] Figure 4 A schematic diagram of the distribution positions of the upper main stimulation part and the lower secondary stimulation part of an acupoint stimulation device for treating Alzheimer's disease according to the present invention;

[0024] Figure 5 A schematic diagram of the distribution positions of the electric needles of an acupoint stimulation device for treating Alzheimer's disease according to the present invention;

[0025] Figure 6 This is a schematic diagram of the total distance traveled by each group of mice in the water maze before electroacupuncture intervention in one embodiment of the present invention;

[0026] Figure 7 This is a schematic diagram of the latency period of the water maze test of each group of mice before electroacupuncture intervention in one embodiment of the present invention;

[0027] Figure 8 This is a schematic diagram of the percentage of quadrant distance of the water maze experimental platform of each group of mice before electroacupuncture intervention in one embodiment of the present invention;

[0028] Fig. 9 This is a schematic diagram of the number of times each group of mice crossed the platform in a water maze experiment before electroacupuncture intervention in one embodiment of the present invention;

[0029] Fig.10 This is a schematic diagram of the total distance traveled in the water maze by each group of mice after electroacupuncture intervention in one embodiment of the present invention;

[0030] Fig.11 This is a schematic diagram of the latency period of the water maze test of each group of mice after electroacupuncture intervention in one embodiment of the present invention;

[0031] Fig.12This is a schematic diagram of the percentage of quadrant distance of the water maze experimental platform of each group of mice after electroacupuncture intervention in one embodiment of the present invention;

[0032] Fig.13 This is a schematic diagram of the dark avoidance latency period of each group of mice before electroacupuncture intervention in one embodiment of the present invention;

[0033] Fig.14 This is a schematic diagram of the number of errors in the dark box avoidance test of each group of mice before electroacupuncture intervention in one embodiment of the present invention;

[0034] Fig.15 This is a schematic diagram of the dark avoidance latency of each group of mice after electroacupuncture intervention in one embodiment of the present invention;

[0035] Fig.16 This is a schematic diagram of the number of errors in the dark box avoidance test in each group of mice after electroacupuncture intervention in one embodiment of the present invention;

[0036] Fig.17 This is a schematic diagram of mitochondrial membrane potential of each group of mice after electroacupuncture intervention in one embodiment of the present invention;

[0037] Fig.18 This is a schematic diagram of the mitochondrial ATP (adenosine triphosphate) content of each group of mice after electroacupuncture intervention in one embodiment of the present invention;

[0038] Fig.19 This is a schematic diagram of the mitochondrial swelling degree of each group of mice after electroacupuncture intervention in one embodiment of the present invention;

[0039] Fig. 20 This is a schematic diagram of the mitochondrial ROS (reactive oxygen species) content in each group of mice after electroacupuncture intervention in one embodiment of the present invention.

[0040] Reference numerals:

[0041] 1-front wearing part; 2-rear wearing part; 3-upper wearing part; 4-upper adjustment strap; 5-rear adjustment strap; 6-battery box; 7-stimulation control part; 8-left stimulation part; 9-rear left stimulation part; 10-rear right stimulation part; 11-upper main stimulation part; 12-upper secondary stimulation part; 13-front upper stimulation part; 14-front lower stimulation part; 15-right stimulation part; 16-chassis; 17-electric needle head. DETAILED DESCRIPTION

[0042] In order to enable those skilled in the art to better understand the technical solution of the present invention, the present invention is described in detail through specific embodiments. However, it should be understood that the provision of specific embodiments is only for a better understanding of the present invention, and they should not be understood as limitations of the present invention. In the description of the present invention, it should be understood that the terms used are only for the purpose of description and cannot be understood as indicating or implying relative importance.

[0043] At present, cognitive rehabilitation equipment used for family treatment of Alzheimer's disease has certain requirements for the patient's motor ability and requires a certain space; the patient's family members need to participate in the care throughout the process, which increases the care burden, and regular and long-term application is difficult to achieve; in addition, the therapeutic effect of some rehabilitation equipment on Alzheimer's disease has not been strictly demonstrated, and there are certain adverse reactions and other problems. In view of the current problems, the present invention proposes an acupoint stimulation device for treating Alzheimer's disease and a method of use thereof, which refers to the treatment mode of transcranial direct current stimulation, adopts variable frequency pulses, and can generate high and low alternating pulse frequencies at the electrode, and based on the theory of traditional Chinese acupuncture, accurately stimulates the electrode to the acupoint, aiming to assist electroacupuncture treatment of Alzheimer's disease and improve the overall efficacy of AD treatment. Provide patients and their families with a self-operable wearable device based on the theory of traditional Chinese acupuncture, which can simulate electroacupuncture stimulation and stimulate specific acupoints to assist in improving the cognitive function of AD patients, improve mental and behavioral symptoms, delay the progression of AD, and improve the overall efficacy of AD treatment. The wearable device can be used for mild, moderate and severe AD patients, and the patients can complete the treatment in a quiet and lying state, which can reduce the burden of family care of the patients to a certain extent and is conducive to long-term family treatment of the patients. The present invention is described in detail below through embodiments in conjunction with the accompanying drawings.

[0044] Embodiment 1

[0045] This embodiment discloses an acupoint stimulation device for treating Alzheimer's disease. Figure 1 As shown, it includes: a front wearing part 1, a rear wearing part 2, an upper wearing part 3, a connecting part, a stimulation generating part, a stimulation controlling part 7 and a stimulation part.

[0046] like Figure 1 and Figure 2 As shown, the front wearing part 1, the rear wearing part 2 and the upper wearing part 3 are connected by a connecting part, the connecting part includes an upper adjusting belt 4 and a rear adjusting belt 5, the upper wearing part 3 is connected to the front wearing part 1 through the upper adjusting belt 4, and the rear wearing part 2 is connected to the front wearing part 1 through the rear adjusting belt 5. At least one stimulation part is arranged on each of the front wearing part 1, the rear wearing part 2 and the upper wearing part 3, and the stimulation part is arranged at the inner middle part and both sides of the front wearing part 1, the inner middle part of the rear wearing part 2, and the lower side of the upper wearing part 3.

[0047] like Figure 3 As shown, the number of stimulation parts arranged in the middle of the inner side of the front wearing part 1 is 2, namely the front upper stimulation part 13 and the front lower stimulation part 14, the stimulation parts arranged on both sides of the front wearing part 1 are the left stimulation part 8 and the right stimulation part 15, and the number of stimulation parts arranged in the middle of the inner side of the rear wearing part 2 is 2, namely the rear left stimulation part 9 and the rear right stimulation part 10, which are symmetrically arranged along the midline of the rear wearing part 2, as shown in FIG. Figure 4As shown, the stimulation part arranged at the lower side of the upper wearing part 3 includes an upper main stimulation part 11 and an upper secondary stimulation part 12. The upper secondary stimulation part 12 is distributed in a straight line along four directions of up, down, left and right with the upper main stimulation part 11 as the center. The upper main stimulation part 11 and each upper stimulation part 12 are provided with an independently powered electric needle head 17.

[0048] The front upper stimulation part 13 corresponds to the acupoint Shenting, the front lower stimulation part 134 corresponds to the acupoint Yintang, the left stimulation part 8 and the right stimulation part 15 correspond to the acupoints Taiyang on both sides, the rear left stimulation part 9 and the rear right stimulation part 10 correspond to the acupoints Fengchi on both sides, the upper main stimulation part 11 corresponds to the acupoint Baihui, and the upper secondary stimulation part 12 corresponds to the acupoint Sishencong. That is, the arrangement of the stimulation parts is set according to the arrangement of the acupoints, which is not limited to the content disclosed in this embodiment.

[0049] The stimulation part is electrically connected to the stimulation control part 7, and the stimulation control part 7 is electrically connected to the stimulation generating part; the stimulation generating part is used to generate high-frequency and low-frequency pulse signal waves; the stimulation control part 7 is used to generate a combination of high-frequency and low-frequency pulse signal waves, and a combination of stimulation parts that need to be activated according to the tolerance level of Alzheimer's disease; the stimulation part is used to stimulate the corresponding acupoints according to the combination of high-frequency and low-frequency pulse signal waves, and the combination of stimulation parts that need to be activated.

[0050] like Figure 5 As shown, the stimulation part includes a chassis 16 and independently powered electric needle heads 17 arranged in a matrix on the chassis 16. The electric needle heads 17 are used to measure the resistance of the skin, determine the specific position of the acupoint based on the resistance measurement result, apply high-frequency and low-frequency pulse signal waves to the acupoint through the electric needle heads 17, simulate the depth of electric needle stimulation by regulating the waveform and amplitude of the stimulation voltage / current of the electric needle heads 17, and use variable frequency electric pulses to regulate the stimulation phase and simulate the angle of electric needle stimulation.

[0051] Specifically, the stimulation control unit 7 adjusts the stimulation depth and stimulation angle of the electric needle head 17 of the stimulation unit based on the electromagnetic wave propagation theory. The electromagnetic wave propagation theory is:

[0052] Wavelength (λ) = period (T) * wave speed (V) = wave speed (V) / frequency (f)

[0053] From the above formula, we can know that the propagation speed of electromagnetic waves in the air is constant. By adjusting the frequency of the electromagnetic waves, the wavelength of the electromagnetic waves will change. The focus is determined according to the wavelength change, thereby changing the depth of stimulation; the propagation speed of electromagnetic waves in the air is constant. By adjusting the frequency of the electromagnetic waves, the phase of the electromagnetic waves will change. The optical path difference is changed according to the phase change, thereby changing the inclination angle of the focal axis of stimulation.

[0054] In this embodiment, the electric needle heads 17 are arranged in an array, and preferably, the number of the electric needle heads 17 on the chassis 16 is 51. In this embodiment, the number of the last stimulation parts 12 in each row is 3 or 4.

[0055] The front upper stimulation part and the front lower stimulation part are detachably arranged on the front wearing part, the rear left stimulation part and the rear right stimulation part are detachably arranged on the rear wearing part, and the upper main stimulation part and the upper secondary stimulation part are detachably arranged on the upper wearing part. The stimulation parts can be fixed on the front wearing part 1, the rear wearing part 2 and the upper wearing part 3 by buckles, magnetic suction or tearing.

[0056] The front wearing part 1, the rear wearing part 2 and the upper wearing part 3 can all be finely adjusted relative to the connecting part. The positions of the front wearing part 1, the rear wearing part 2 and the upper wearing part 3 are finely adjusted according to the resistance measurement results obtained by the electric needle head 17 so that the electric needle head 17 is aligned with the acupuncture point.

[0057] Since Alzheimer's disease is clinically characterized by cognitive decline as the core manifestation, and most patients have decreased living ability, accompanied by varying degrees of indifference, depression, anxiety and other mental and behavioral disorders, and also have problems such as decreased sleep quality, in this embodiment, the stimulation control unit 7 can not only alleviate Alzheimer's disease to a certain extent by controlling the pulse signal of the stimulation unit, but also can perform corresponding stimulation for different clinical manifestations of Alzheimer's disease, and can select the corresponding model for stimulation according to the actual accompanying symptoms. For example, for patients with cognitive impairment and decreased daily living ability, a pulse signal with a frequency of 2 / 100Hz can be used to stimulate acupoints such as Yintang, Baihui, Shenting, Sishencong, Fengchi and Taiyang, and this stimulation method can be set to mode one; for Alzheimer's patients with two or more mental and behavioral disorders, a pulse signal with a frequency of 100Hz can be used to stimulate acupoints such as Yintang, Baihui, Shenting, Sishencong, Fengchi and Taiyang, and this stimulation method can be set to mode two.

[0058] The connecting part is a fabric with high elongation and high resilience made of stretch yarn, an elastic band or a slide rail, but when the connecting part is a slide rail, the front wearing part 1, the rear wearing part 2 and the upper wearing part 3 are all sliders arranged on the slide rail. In this embodiment, the high resilience fabric is preferably spandex core-spun yarn. In this embodiment, retractable materials are used to ensure that the size of the equipment can be adjusted according to the different head shapes of the patients. A slide rail is installed on the instrument, and the position of the electrode on the slide rail is adjusted according to the patient's skeletal positioning to ensure accurate acupuncture. The host is a head-mounted portable device, the appearance should be neat, the color should be uniform, without obvious scars, scratches, cracks, deformation and other defects; the text and logos should be clearly visible; the control and adjustment parts should be flexible and reliable.

[0059] The combination of high-frequency and low-frequency pulse signal waves is that the low-frequency pulse signal is 2Hz, the high-frequency pulse signal is 100Hz, and after the high-frequency pulse signal is output for a preset time, the low-frequency pulse signal is output, and the high and low frequencies are output alternately, that is, the pulse signal wave is output at an alternating frequency of 2 / 100Hz. The high-frequency and low-frequency pulse signals stimulate for 1.5 seconds at each frequency, with an interval of 0 seconds. As for the specific waveform parameters of the pulse signal, it can be determined according to actual experiments. In this embodiment, the deviation of the pulse parameters is: deviation <= ±20%, measurement error <= ±10%. In this embodiment, the output amplitude is: a discrete increase with each increment not greater than 1V or 1mA, and the power supply voltage fluctuation range is: voltage fluctuation ±10%, and the impact on the stimulator does not exceed ±10%.

[0060] A battery box 6 is provided on both sides of the front wearing part 1, and a battery is provided inside the battery to power each stimulation part and the control circuit. The battery has a rechargeable battery of 100mAh, or is externally powered. In the present embodiment, the stimulation control part 7 includes a display screen and an alarm unit, the display screen is used to display a combination of high-frequency and low-frequency pulse signal waves, and the parameters are input through the display screen. The alarm unit performs a sound wave or video alarm when the device is in an open circuit or short circuit state or exceeds the maximum set current. The stimulation control part 7 can be fixed to the battery box 6 or the wearing part by means of a buckle or a magnetic buckle. In the present embodiment, the maximum set current does not exceed 5mA±20%, but is not limited to this. The open circuit or short circuit state of the device is: all output controllers are set to the maximum value, and each pair of output terminals is open circuited for 10 minutes, and then short circuited for 5 minutes, and the functions of the device are normal. Power on button and output amplitude adjustment button. It has a timing function, and a sound prompt is issued after the treatment is completed, and then it automatically shuts down. The device is a rechargeable device.

[0061] Embodiment 2

[0062] Based on the same inventive concept, this embodiment discloses a method for using an acupoint stimulation device for treating Alzheimer's disease, which is used for any of the above-mentioned acupoint stimulation devices for treating Alzheimer's disease, comprising the following steps:

[0063] S1 wears the front wearing part 1, the rear wearing part 2 and the upper wearing part 3 on the forehead, the back of the head and the top of the head of the user respectively, and the position of each component can be appropriately adjusted according to the head shape and head dimensions of the user by adjusting the length of the rear adjustment belt 5 and the upper adjustment belt 4.

[0064] S2 detects the skin resistance, determines the exact position of the acupoints, and fine-tunes the positions of the front wearing part 1, the rear wearing part 2, and the upper wearing part 3.

[0065] S3 starts the stimulation generating unit and the stimulation controlling unit 7, and generates a combination of high-frequency and low-frequency pulse signal waves and a combination of stimulation units that need to be activated according to the tolerance level of the Alzheimer's patient, and energizes the electric needle heads 17 on the front wearing part 1, the rear wearing part 2 and the upper wearing part 3 in turn.

[0066] The front upper stimulation part 13 corresponds to the acupuncture point Shen Ting, the front lower stimulation part 14 corresponds to the acupuncture point Yin Tang, the left stimulation part 8 and the right stimulation part 15 correspond to the acupuncture point Taiyang (on both sides), the rear left stimulation part 9 and the rear right stimulation part 10 correspond to the acupuncture point Feng Chi (on both sides), wherein taking the acupuncture point Yin Tang as an example, first activate the electric needle head 17 located at the center of the matrix arrangement, and conduct a test based on the user's feedback, and sequentially activate the electric needle heads 17 at the upper, lower, left and right positions of the center of the matrix arrangement until the best stimulation position of the acupuncture point is adjusted. In addition, the upper main stimulation part 11 corresponds to the acupuncture point Baihui, and the upper stimulation part 12 corresponds to the acupuncture point Si Shen Cong. When the position of the Baihui acupuncture point is fixed, the upper stimulation part 12 is activated from near to far in sequence, and when the appropriate stimulation position is reached, the adjustment is stopped. The above-mentioned stimulation parts use 2 / 100Hz variable frequency pulses to achieve the best stimulation effect.

[0067] S4 If the power supply reaches the preset time or the patient feels uncomfortable, the power supply is stopped and the acupoint stimulation ends.

[0068] Each acupoint is an effective acupoint verified by experiments for Alzheimer's disease, so it has good specificity for this particular population. Secondly, the stimulation part of each acupoint is arranged in a matrix, and each electric needle head 17 is independently powered. The stimulation position of each acupoint can be adjusted by a controller, and the intensity of stimulation of each acupoint can be adjusted. It can be suitable for different populations with different acupoint stimulation intensities.

[0069] Embodiment 3

[0070] This embodiment verifies the method of the present invention through specific experiments. This embodiment adopts a prospective randomized single-blind controlled trial. 19 patients with Alzheimer's disease who meet the inclusion and exclusion criteria are randomly divided into an electroacupuncture group and a sham electroacupuncture group in a ratio of 1:1. Their baseline conditions are shown in Table 1. The electroacupuncture group is treated with electroacupuncture combined with basic drugs. The acupoints are selected: Baihui, Yintang, Taiyang, Sishencong, Fengchi. During the acupuncture process, the patient is required to have a sore, numb and swollen feeling. After the acupuncture is completed, the electroacupuncture is connected. The electroacupuncture waveform is a sparse and dense wave with a frequency of 2 / 100Hz. The current intensity is adjusted within the range of 1-5mA, depending on the patient's tolerance. The sham electroacupuncture group selects acupoints 2cm away from the above-mentioned acupoints, and shallowly punctures 1-3mm to ensure that the acupuncture needles are left subcutaneously. After acupuncture, the electroacupuncture is connected without electricity. Patients in the EA group and the sham EA group completed the Alzheimer's disease assessment scale cognition subscale (ADAS-Cog scale) (as shown in Table 2) before treatment, 4 weeks, 8 weeks, and 12 weeks after treatment, and completed the Activity of daily living scale (ADL) (as shown in Table 3), Neuropsychiatric inventory (NPI) (as shown in Table 4), and NPI caregiver distress rating scale (as shown in Table 5) before treatment and 12 weeks after treatment. By comparing with the sham EA group, the differences in ADAS-Cog scale, ADL scale, NPI scale, and NPI caregiver distress rating scale between the two groups were compared to explore the effects of EA on different cognitive domains, patients' daily living ability, patients' mental and behavioral symptoms, and caregiver burden, and then explore the efficacy of EA. Both groups were treated once every other day, 3 times a week, 4 weeks as a course of treatment, a total of 3 courses, 12 weeks. ADAS-Cog scale: mainly includes 12 items such as memory, attention, language, visual space, comprehension and operation ability, which are used to assess the severity of cognitive dysfunction. The total score is 75 points. The lower the score, the better the cognitive function. ADL is used to assess the patient's daily living ability, including basic daily living ability and instrumental daily living ability. The higher the score, the worse the living ability. NPI is used to assess the patient's mental and behavioral symptoms, including patient scores and caregiver distress scores. The higher the score, the more severe the patient's mental and behavioral symptoms and the higher the degree of distress of the caregiver.

[0071] Through the above clinical observations, the following conclusions can be drawn preliminarily: setting the electroacupuncture parameters to sparse-dense wave 2 / 100Hz, electroacupuncture at Baihui, Yintang, Taiyang, Sishencong, and Fengchi points for 20 minutes each time, 3 times a week, and 12 weeks of treatment can improve the cognitive ability of Alzheimer's patients to a certain extent, slow the rate of decline in Alzheimer's patients' daily abilities, and reduce the distress of caregivers.

[0072] In terms of electroacupuncture treatment parameters, this embodiment confirms through animal experiments and clinical studies that the sparse-dense wave of 2 / 100 Hz has the best therapeutic effect.

[0073] Forty 5-month-old SPF (Specific pathogen Free) male SAMP8 mice were randomly divided into 4 groups, with 10 mice in each group, and received electroacupuncture intervention with EA1: 2 / 100Hz, EA2: 2Hz, EA3: 100Hz and acupuncture without electricity intervention, respectively; 10 SPF male SAMR1 mice were selected as healthy controls, and behavioral tests were performed on mice in each group before and 3 months after intervention: Morris water maze and dark box avoidance test; and brain mitochondria of mice in each group were extracted after intervention, and mitochondrial reactive oxygen species, mitochondrial ATP content, mitochondrial membrane swelling, and mitochondrial membrane potential were measured, and the results of behavioral experiments and mitochondrial related indicators of mice in each group were compared and analyzed. The results of water maze test of mice in each group before electroacupuncture intervention are shown in Table 6.

[0074] Table 1 Baseline conditions of subjects in the electroacupuncture group and the sham electroacupuncture group

[0075]

[0076] Table 2 Comparison of ADAS-Cog scores between the two groups before and after treatment

[0077]

[0078] Table 3 Comparison of ADL scale scores between the two groups before and after treatment

[0079]

[0080] Note: * indicates P ≤ 0.05.

[0081] Table 4 Comparison of NPI scores between the two groups before and after treatment

[0082]

[0083] Table 5 Comparison of NPI caregiver distress scores between the two groups before and after treatment

[0084]

[0085] Table 6 Water maze test results of mice in each group before electroacupuncture intervention

[0086]

[0087] Figure 6 This is a schematic diagram of the total distance traveled by each group of mice in the water maze before electroacupuncture intervention in this example; Figure 7This is a schematic diagram of the latency period of the water maze test of each group of mice before electroacupuncture intervention in this example; Figure 8 This is a schematic diagram of the percentage of quadrant distance of the water maze experimental platform of each group of mice before electroacupuncture intervention in this embodiment; Fig. 9 The figure is a schematic diagram of the number of times each group of mice crossed the platform in the water maze experiment before electroacupuncture intervention in this embodiment. Among them, there was no significant difference (P>0.05) in the total distance, latency, platform quadrant distance percentage, and number of times crossing the platform in the water maze experiment between the SAMP8 model group mice and the SAMR1 normal group, and between the SAMP8 mice in the electroacupuncture intervention groups, and the mice in each group were comparable. The results of the water maze test before and after electroacupuncture intervention of each group of mice are shown in Table 7.

[0088] Fig.10 This is a schematic diagram of the total distance traveled by each group of mice in the water maze after electroacupuncture intervention in this example; Fig.11 This is a schematic diagram of the latency period of the water maze test in each group of mice after electroacupuncture intervention in this example; Fig.12 Schematic diagram of the percentage of the quadrant where the platform of the water maze experiment is located in each group of mice after electroacupuncture intervention in this embodiment. Compared with the SAMR1 normal group, the total distance of the water maze experiment of the mice in the SAMP8 model group was prolonged, and the latency was prolonged, and the difference was statistically significant (P < 0.05); the percentage of the platform quadrant distance decreased, and the number of crossing the platform increased (P > 0.05). Compared with the mice in the model control group, the total distance of the water maze of the mice in the electroacupuncture frequency group of 2 / 100Hz was shortened, the latency was shortened, and the percentage of the platform quadrant increased, and the difference was statistically significant (P < 0.05). The test results of the dark box avoidance experiment before electroacupuncture intervention of each group of mice are shown in Table 8.

[0089] Table 7 Water maze test results of mice in each group after electroacupuncture intervention

[0090]

[0091] Note: Compared with the normal group, *P<0.05; compared with the model control group, #P<0.05

[0092] Table 8 Results of dark box avoidance experiment in each group of mice before electroacupuncture intervention

[0093] Group n Incubation period(s) Number of errors (times) SAMR1 group 10 290.40±12.78 0.70±0.67 SAMP8 group 10 275.00±34.77 0.60±0.52 EA12 / 100Hz) group 10 278.10±17.84 0.80±0.79 EA2(2Hz) Group 10 272.00±211.23 0.90±0.88 EA3(100Hz) group 10 281.40±12.92 1.00±0.82

[0094] Fig.13 This is a schematic diagram of the dark avoidance latency period of each group of mice before electroacupuncture intervention in this example; Fig.14Schematic diagram of the number of errors in the dark box avoidance test of each group of mice before electroacupuncture intervention in this embodiment. The dark avoidance latency and number of errors of the dark box avoidance test of the SAMP8 model group mice were compared with the SAMR1 normal group, and the dark avoidance latency and number of errors of the dark box avoidance test of the electroacupuncture intervention groups of mice were compared with the SAMP8 model group mice. There was no significant difference (P>0.05) in the data of each group, and they were comparable. The test results of the dark box avoidance test of each group of mice after electroacupuncture intervention are shown in Table 9.

[0095] Table 9 Results of dark box avoidance experiment after electroacupuncture intervention in mice of each group

[0096] Group n Incubation period(s) Number of errors (times) SAMR1 group 10 291.60±8.47 0.60±0.52 SAMP8 group 10 192.70±32.44* 3.90±1.20* EA1(2 / 100Hz) group 10 252.10±23.14# 1.70±0.67# EA2(2Hz) Group 10 194.50±28.41 3.10±1.20 EA3(100Hz) group 10 200.10±28.66 3.30±0.95

[0097] Note: Compared with the normal group, *P<0.05; compared with the model control group, #P<0.05

[0098] Fig.15 This is a schematic diagram of the dark avoidance latency period of each group of mice after electroacupuncture intervention in this example; Fig.16 The figure is a schematic diagram of the number of errors in the dark box avoidance test of each group of mice after electroacupuncture intervention in this embodiment. Compared with the normal SAMR1 group, the latency of the dark box avoidance test of the SAMP8 model group mice was shortened, and the number of errors increased, and the difference was statistically significant (P < 0.05); compared with the model control group mice, the latency of the dark box avoidance test of the mice in the 2 / 100Hz electroacupuncture frequency group was prolonged, and the number of errors decreased, and the difference was statistically significant (P < 0.05). The results of mitochondrial index detection of each group of mice after electroacupuncture intervention are shown in Table 10.

[0099] Table 10 Results of brain mitochondrial index detection after electroacupuncture intervention in mice in each group

[0100]

[0101] Fig.17 Schematic diagram of mitochondrial membrane potential of mice in each group after electroacupuncture intervention in this example; compared with the SAMR1 normal group, the mitochondrial membrane potential of mice in the SAMP8 model group increased, and the difference was statistically significant (P < 0.05); compared with the mice in the model control group, the mitochondrial membrane potential of mice in the electroacupuncture frequency 2 / 100 Hz group decreased, and the difference was statistically significant (P < 0.05). Fig.18 Schematic diagram of mitochondrial ATP (adenosine triphosphate) content in each group of mice after electroacupuncture intervention in this example; compared with the SAMR1 normal group, the mitochondrial ATP content in the SAMP8 model group mice was reduced, and the difference was statistically significant (P < 0.05); compared with the model control group mice, the mitochondrial ATP content in the electroacupuncture frequency 2 / 100Hz, 2Hz group, and 100Hz group mice was increased, and the difference was statistically significant (P < 0.05). Fig.19Schematic diagram of mitochondrial swelling in each group of mice after electroacupuncture intervention in this example; compared with the SAMR1 normal group, the mitochondrial membrane swelling of the mice in the SAMP8 model group was increased, and the difference was statistically significant (P < 0.05); compared with the mice in the model control group, the mitochondrial membrane swelling of the mice in the electroacupuncture frequency of 2 / 100 Hz group was reduced, and the difference was statistically significant (P < 0.05). Fig. 20 The figure is a schematic diagram of the mitochondrial ROS (reactive oxygen species) content of each group of mice after electroacupuncture intervention in this example. Compared with the SAMR1 normal group, the mitochondrial ROS content of the SAMP8 model group mice increased, and the difference was statistically significant (P < 0.05); compared with the model control group mice, the mitochondrial ROS content of the 2 / 100Hz, 2Hz, and 100Hz groups of mice decreased, and the difference was statistically significant (P < 0.05).

[0102] Based on the above animal experimental results, we concluded that the electroacupuncture frequency of 2 / 100Hz sparse-dense waves is the optimal electroacupuncture frequency for intervention in the treatment of dementia.

[0103] In the clinical trial, a prospective randomized controlled design was adopted. 42 patients with Alzheimer's disease who met the inclusion criteria were randomly assigned to the 2Hz electroacupuncture group, the 100Hz electroacupuncture group, and the 2 / 100Hz electroacupuncture group in a ratio of 1:1:1. The baseline conditions of the subjects in different electroacupuncture groups are shown in Table 11. The acupoints selected were Baihui, Sishencong, Yintang, Taiyang, Fengchi, Zhongwan, Tianshu, Qihai, Guanyuan, Zusanli, and Taixi. Each group was connected to three groups of electroacupuncture (Baihui-Yintang, bilateral Taiyang, and bilateral Fengchi). The parameters of the 2Hz electroacupuncture group were set as continuous wave 2Hz, the 100Hz electroacupuncture group was set as continuous wave 100Hz, and the 2 / 100Hz electroacupuncture group was set as sparse and dense wave 2 / 100Hz. The intensity was based on the patient's tolerance, 20 minutes / time, once every other day, 3 times / week, for 12 consecutive weeks. All three groups of patients were treated with conventional Western medicine.

[0104] Table 11 Baseline conditions of subjects in different electroacupuncture groups

[0105]

[0106] By analyzing the changes in ADAS-Cog, Mini-Mental State Examination (MMSE), ADL, and NPI scores of the three groups of patients before and after treatment, as shown in Tables 12-19, the effects of different parameters on cognitive function, daily living ability, psychiatric and behavioral symptoms, and caregiver distress in patients with Alzheimer's disease were compared.

[0107] Table 12 Comparison of ADAS-Cog scores in different electroacupuncture groups

[0108]

[0109] Table 13 Comparison of MMSE scores in different electroacupuncture groups

[0110]

[0111] Table 14 Multiple comparison of MMSE score differences among the three groups of patients after 12 weeks of treatment

[0112] Mean Difference P 2Hz group Vs100Hz group -1.99 0.444 2Hz group Vs2 / 100Hz group* -3.97b 0.011 100Hz group Vs2 / 100Hz group -2.77e 0.075

[0113] Note: a = 2Hz group - 100Hz group, b = 2Hz group - 2 / 100Hz group, e = 100Hz group - 2 / 100Hz group

[0114] There was a statistically significant difference in the MMSE values ​​before and after treatment between the 2Hz group and the 2 / 100Hz group (P=0.011<0.05), and the difference in MMSE in the 2 / 100Hz group was higher than that in the 2Hz electroacupuncture group, indicating that 2 / 100Hz is superior to 2Hz in improving cognitive impairment. There was no statistically significant difference in the MMSE values ​​between the 2Hz group and the 100Hz group, and between the 100Hz group and the 2 / 100Hz group (P>0.05).

[0115] Table 15 Comparison of the difference in ADL scores among the three groups of patients before and after treatment

[0116]

[0117] Table 16 Comparison of BADL scores of the three groups of patients before and after treatment

[0118]

[0119] Table 17 Comparison of IADL scores of the three groups of patients before and after treatment

[0120]

[0121] Table 18 Comparison of the difference in NPI patient scores among the three groups of patients before and after treatment

[0122]

[0123] Table 19 Comparison of the difference in NPI caregiver distress scores among the three groups before and after treatment

[0124]

[0125] Through clinical research, we found that electroacupuncture parameters set to 2 / 100Hz have a better comprehensive therapeutic effect on AD patients' cognition, daily living ability, and mental and behavioral symptoms.

[0126] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit them. Although the present invention has been described in detail with reference to the above embodiments, ordinary technicians in the relevant field should understand that the specific implementation of the present invention can still be modified or replaced by equivalents, and any modification or equivalent replacement that does not deviate from the spirit and scope of the present invention should be included in the protection scope of the claims of the present invention. The above content is only a specific implementation of the present application, but the protection scope of the present application is not limited thereto. Any technician familiar with the technical field can easily think of changes or replacements within the technical scope disclosed in the present application, which should be included in the protection scope of the present application. Therefore, the protection scope of the present application shall be based on the protection scope of the claims.

Claims

1. An acupoint stimulation device for treating Alzheimer's disease, characterized in that: include: A front wearing part, a rear wearing part, an upper wearing part, a connecting part, a stimulation generating part, a stimulation controlling part and a stimulation part; The front wearing part, the rear wearing part and the upper wearing part are connected by a connecting part, and at least one stimulation part is arranged on each of the front wearing part, the rear wearing part and the upper wearing part, and the stimulation part is electrically connected to the stimulation control part, and the stimulation control part is electrically connected to the stimulation generating part; The stimulation generating unit is used to generate high-frequency and low-frequency pulse signal waves; The stimulation control unit is used to generate a combination of high-frequency and low-frequency pulse signal waves, and a combination of stimulation units that need to be activated according to the type of Alzheimer's disease and the patient's tolerance level; generate a combination of high-frequency and low-frequency pulse signal waves, and a combination of stimulation units that need to be activated; The stimulation part is used to stimulate the corresponding acupuncture points according to the combination of high-frequency and low-frequency pulse signal waves and the combination of stimulation parts that need to be activated.

2. The acupoint stimulation device for treating Alzheimer's disease according to claim 1, characterized in that: The stimulation part includes a chassis and independently powered electric needle heads arranged in a matrix on the chassis. The electric needle heads are used to measure the resistance of the skin and determine the specific positions of the acupoints based on the resistance measurement results. The electric needle heads are used to measure the resistance of the skin and determine the specific positions of the acupoints based on the resistance measurement results. The stimulation voltage / current waveform and amplitude of the electric needle heads are adjusted to simulate the depth of electric needle stimulation. Variable frequency electric pulses are used to adjust the stimulation phase and simulate the angle of electric needle stimulation.

3. The acupoint stimulation device for treating Alzheimer's disease according to claim 2, characterized in that: There are two stimulation parts arranged in the middle of the inner side of the front wearing part, namely the upper front stimulation part and the lower front stimulation part; the stimulation parts arranged on both sides of the front wearing part are the left stimulation part and the right stimulation part; there are two stimulation parts arranged in the middle of the inner side of the rear wearing part, namely the rear left stimulation part and the rear right stimulation part, which are symmetrically arranged along the midline of the rear wearing part; the stimulation part arranged on the lower side of the upper wearing part includes an upper main stimulation part and an upper secondary stimulation part, and the upper stimulation part is distributed in a straight line along four directions of up, down, left and right with the upper main stimulation part as the center; the upper main stimulation part and each of the upper stimulation parts are provided with an electric needle head with independent power supply.

4. The acupoint stimulation device for treating Alzheimer's disease according to claim 3, characterized in that: The front upper stimulation part corresponds to the acupuncture point Shenting, the front lower stimulation part corresponds to the acupuncture point Yintang, the left stimulation part and the right stimulation part correspond to the acupuncture points Taiyang on both sides, the rear left stimulation part and the rear right stimulation part correspond to the acupuncture points Fengchi on both sides, the upper main stimulation part corresponds to the acupuncture point Baihui, and the upper secondary stimulation part corresponds to the acupuncture point Si Shencong.

5. The acupoint stimulation device for treating Alzheimer's disease according to claim 4, characterized in that: The front upper stimulation portion and the front lower stimulation portion are detachably arranged on the front wearing portion, the rear left stimulation portion and the rear right stimulation portion are detachably arranged on the rear wearing portion, and the upper main stimulation portion and the upper secondary stimulation portion are detachably arranged on the upper wearing portion.

6. The acupoint stimulation device for treating Alzheimer's disease according to claim 2, characterized in that: The front wearing part, the rear wearing part and the upper wearing part can all be finely adjusted relative to the connecting part. The positions of the front wearing part, the rear wearing part and the upper wearing part are finely adjusted according to the resistance measurement results obtained by the electric needle head so that the electric needle head is aligned with the acupuncture point.

7. The acupoint stimulation device for treating Alzheimer's disease according to claim 2, characterized in that: The connecting part is a high-extension and high-elasticity fabric made of stretch yarn, an elastic band or a slide rail. However, when the connecting part is a slide rail, the front wearing part, the rear wearing part and the upper wearing part are all sliders arranged on the slide rail.

8. The acupoint stimulation device for treating Alzheimer's disease according to claim 1, characterized in that: The combination of the high-frequency and low-frequency pulse signal waves is that the low-frequency pulse signal is 2Hz and the high-frequency pulse signal is 100Hz. After the high-frequency pulse signal is output for a preset time, the low-frequency pulse signal is output, and the high and low frequencies are output alternately.

9. The acupoint stimulation device for treating Alzheimer's disease according to claim 1, characterized in that: The stimulation control unit includes a display screen and an alarm unit. The display screen is used to display the combination of the high-frequency and low-frequency pulse signal waves, and parameter input is performed through the display screen. The alarm unit performs sound wave or video alarm when the device is in an open circuit or short circuit state or exceeds the maximum set current.

10. A method for using an acupoint stimulation device for treating Alzheimer's disease, characterized in that: The acupoint stimulation device for treating Alzheimer's disease as claimed in any one of claims 1 to 9 comprises the following steps: The front wearing part, the rear wearing part and the upper wearing part are respectively worn on the forehead, the back of the head and the top of the head of the user; Detecting skin resistance to determine the exact location of the acupoints, and fine-tuning the positions of the front wearing part, the rear wearing part, and the upper wearing part; The stimulation generating unit and the stimulation controlling unit are activated to generate a combination of high-frequency and low-frequency pulse signal waves and a combination of stimulation units to be activated according to the type of Alzheimer's disease and the tolerance of the patient, and the electric needle heads on the front wearing unit, the rear wearing unit and the upper wearing unit are energized in sequence; If the power is supplied for a preset time or the patient feels uncomfortable, the power is stopped and the acupoint stimulation ends.